Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer

被引:26
|
作者
Lv, Zhengtong [1 ,2 ]
Wang, Jianlong [1 ]
Wang, Xuan [1 ]
Mo, Miao [3 ]
Tang, Guyu [3 ]
Xu, Haozhe [3 ]
Wang, Jianye [1 ,2 ]
Li, Yuan [4 ]
Liu, Ming [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Natl Ctr Gerontol,Dept Urol, Beijing, Peoples R China
[2] Peking Union Med Coll & Chinese Acad Med Sci, Grad Sch, Beijing, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金
中国国家自然科学基金;
关键词
prostate cancer; TCGA; MSKCC; ferroptosis; prognosis; biochemical recurrence; NATURAL-HISTORY; OVEREXPRESSION; AKR1C1; PROGRESSION; SYNTHASE; SLC1A5; FANCD2; TUMORS; CELLS; ACSL4;
D O I
10.3389/fcell.2021.666025
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ferroptosis induced by lipid peroxidation is closely related to cancer biology. Prostate cancer (PCa) is not only a malignant tumor but also a lipid metabolic disease. Previous studies have identified ferroptosis as an important pathophysiological pathway in PCa development and treatment, but its role in the prognosis of PCa is less well known. In this study, we constructed a nine-ferroptosis-related gene risk model that demonstrated strong prognostic and therapeutic predictive power. The higher risk score calculated by the model was significantly associated with a higher ferroptosis potential index, higher Ki67 expression, higher immune infiltration, higher probability of biochemical recurrence, worse clinicopathological characteristics, and worse response to chemotherapy and antiandrogen therapy in PCa. The mechanisms identified by the gene set enrichment analysis suggested that this signature can accurately distinguish high- and low-risk populations, which is possibly closely related to variations in steroid hormone secretion, regulation of endocrine processes, positive regulation of humoral immune response, and androgen response. Results of this study were confirmed in two independent PCa cohorts, namely, The Cancer Genome Atlas cohort and the MSK-IMPACT Clinical Sequencing Cohort, which contributed to the body of scientific evidence for the prediction of biochemical recurrence in patients with PCa. In addition, as the main components of this signature, the effects of the AIFM2 and NFS1 genes on ferroptosis were evaluated and verified by in vivo and in vitro experiments, respectively. The above findings provided new insights and presented potential clinical applications of ferroptosis in PCa.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
    Li, Zhufeng
    Yuan, Fang
    Liu, Xin
    Wei, Jianming
    Liu, Tong
    Li, Weidong
    Li, Chuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
    Ye, Ying
    Dai, Qinjin
    Li, Shuhong
    He, Jie
    Qi, Hongbo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [43] Ferroptosis-related gene signature for predicting prognosis and identifying potential therapeutic drug in EGFR wild-type lung adenocarcinoma
    Zhang, Chuankai
    Wu, Qi
    Yang, Hongwei
    Zhang, Hui
    Liu, Changqing
    Yang, Bo
    Hu, Qingsong
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [44] Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
    Wang, Qingbin
    Wang, Bingkun
    Ma, Xiaowu
    Zhuang, Hongkai
    Xie, Zhiqin
    Tang, Chenwei
    Tan, Wenliang
    Yang, Lei
    Shang, Changzhen
    Chen, Yajin
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1 - 16
  • [45] Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients
    Xiong, Kaifen
    Wang, Zheng
    Hounye, Alphonse Houssou
    Peng, Li
    Zhang, Jianglin
    Qi, Min
    APOPTOSIS, 2023, 28 (5-6) : 840 - 859
  • [46] Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma
    Wan, Rong-Jun
    Peng, Wang
    Xia, Qin-Xuan
    Zhou, Hong-Hao
    Mao, Xiao-Yuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (08) : 973 - 986
  • [47] Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
    Lei Zhu
    Fugui Yang
    Lingwei Wang
    Lin Dong
    Zhiyuan Huang
    Guangxue Wang
    Guohan Chen
    Qinchuan Li
    Cancer Cell International, 21
  • [48] Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma
    Zhuo, Shenghua
    Chen, Zhimin
    Yang, Yibei
    Zhang, Jinben
    Tang, Jianming
    Yang, Kun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma
    Lin, Xijin
    Shao, Kongfeng
    Lin, Zhuangbin
    Liang, Qiandong
    Li, Xiaoyan
    Chen, Haiyan
    Wu, Junxin
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [50] Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients
    Kaifen Xiong
    Zheng Wang
    Alphonse Houssou Hounye
    Li Peng
    Jianglin Zhang
    Min Qi
    Apoptosis, 2023, 28 : 840 - 859